Literature DB >> 20878448

Operative treatment of subcortical metastatic tumours in the central region.

J Walter1, S A Kuhn, A Waschke, R Kalff, C Ewald.   

Abstract

The operative treatment of subcortical metastatic tumours within the paracentral area is still under discussion. Against the background of possible new postoperative neurological deficits and of evolving new radio oncological techniques, the indication for surgery is limited only to a subgroup of patients. In this retrospective study we present the clinical results after operative treatment of metastases within the central and paracentral brain region, with an emphasis on the short-term and mid-term functional outcome. We report on 20 patients suffering from subcortical brain metastases within the primary sensorimotor area, with a median volume on MRI-scans of 8.18 cm³. Patients were admitted to our department with a progressive hemiparesis (n = 11), focal seizures (n = 6) or other unspecific symptoms (n = 3) like headache, nausea, and neuropsychological disturbances, respectively. After updated MRI- and fMRI-scanning, intensive electrophysiological testing including MEP-brain mapping and interdisciplinary tumour-board discussion of each case, those patients were evaluated for surgery. Early postoperative control was done by MRI within the first 48 h. Follow-up took place in our outpatient department, assessing clinical criteria two and 6 weeks postoperatively, followed by clinical control and MRI-scans every 3 months. In all patients, surgery was performed under general anaesthesia, cranial neuro navigation and intraoperative motor cortex stimulation. Surgery and the early postoperative course were uneventful in all cases. After a 6 months follow-up, two patients had died. The motor deficits improved in seven patients and remained unchanged in four cases. One patient suffered from a new persistent hemiparesis. A temporary paresis occurred in two cases. In five patients there was no motor deficit pre- and postoperatively. The Karnofsky Performance Status improved in ten patients 6 months after surgery. Quality of Life, measured by the FACT-Br score, improved in 12 patients and remained unchanged in one patient. With modern techniques like fMRI-guided cranial neuronavigation and intraoperative neuromonitoring including direct stimulation of the motor cortex, microsurgical resection of subcortical paracentral metastases is feasible with an acceptable risk of neurological deterioration. Even preexistent deficits can improve with positive influence on the quality of life for oncological patients, being disabled by the symptoms caused by the cerebral lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20878448     DOI: 10.1007/s11060-010-0420-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Surgical treatment of supplementary motor area lesions.

Authors:  Mustafa Aziz Hatipoğlu; Sujit Prabhu; Jeffrey Weinberg; Komal Shah; Raymond Sawaya
Journal:  Turk Neurosurg       Date:  2009-07       Impact factor: 1.003

Review 2.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

Authors:  May N Tsao; Nancy S Lloyd; Rebecca K S Wong; Eileen Rakovitch; Edward Chow; Normand Laperriere
Journal:  Cancer Treat Rev       Date:  2005-06       Impact factor: 12.111

Review 3.  The diagnosis and management of brain metastases.

Authors:  M J van den Bent
Journal:  Curr Opin Neurol       Date:  2001-12       Impact factor: 5.710

4.  Awake surgery with continuous motor testing for resection of brain tumors in the primary motor area.

Authors:  Nobusada Shinoura; Mizuho Yoshida; Ryoji Yamada; Yusuke Tabei; Kuniaki Saito; Yuichi Suzuki; Yoshihiro Takayama; Kazuo Yagi
Journal:  J Clin Neurosci       Date:  2008-12-13       Impact factor: 1.961

5.  Image-guided craniotomy for cerebral metastases: techniques and outcomes.

Authors:  Tze-Ching Tan; Peter McL Black
Journal:  Neurosurgery       Date:  2007-07       Impact factor: 4.654

6.  The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.

Authors:  V Mor; L Laliberte; J N Morris; M Wiemann
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

Review 7.  Management of brain metastases: the indispensable role of surgery.

Authors:  George Al-Shamy; Raymond Sawaya
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients.

Authors:  Stefan S Kim; Ian E McCutcheon; Dima Suki; Jeffrey S Weinberg; Raymond Sawaya; Frederick F Lang; David Ferson; Amy B Heimberger; Franco DeMonte; Sujit S Prabhu
Journal:  Neurosurgery       Date:  2009-05       Impact factor: 4.654

Review 9.  Stereotactic radiosurgery for the treatment of brain metastases.

Authors:  Falk Müller-Riemenschneider; Angelina Bockelbrink; Iris Ernst; Christoph Schwarzbach; Christoph Vauth; J-Matthias Graf von der Schulenburg; Stefan N Willich
Journal:  Radiother Oncol       Date:  2009-01-08       Impact factor: 6.280

10.  Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients.

Authors:  G Evren Keles; David A Lundin; Kathleen R Lamborn; Edward F Chang; George Ojemann; Mitchel S Berger
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

View more
  12 in total

1.  Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.

Authors:  Aditya Iyer; Casey H Halpern; Gerald A Grant; Sayantan Deb; Gordon H Li
Journal:  Cureus       Date:  2016-12-07

Review 2.  Current approaches to the treatment of metastatic brain tumours.

Authors:  Taofeek K Owonikoko; Jack Arbiser; Amelia Zelnak; Hui-Kuo G Shu; Hyunsuk Shim; Adam M Robin; Steven N Kalkanis; Timothy G Whitsett; Bodour Salhia; Nhan L Tran; Timothy Ryken; Michael K Moore; Kathleen M Egan; Jeffrey J Olson
Journal:  Nat Rev Clin Oncol       Date:  2014-02-25       Impact factor: 66.675

3.  Surgery on motor area metastasis.

Authors:  Marta Rossetto; Pietro Ciccarino; Giuseppe Lombardi; Giuseppe Rolma; Diego Cecchin; Alessandro Della Puppa
Journal:  Neurosurg Rev       Date:  2015-07-17       Impact factor: 3.042

Review 4.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

Review 5.  Resection of supratentorial gliomas: the need to merge microsurgical technical cornerstones with modern functional mapping concepts. An overview.

Authors:  Giannantonio Spena; Pier Paolo Panciani; Marco Maria Fontanella
Journal:  Neurosurg Rev       Date:  2014-10-21       Impact factor: 3.042

Review 6.  Neuronavigation in the surgical management of brain tumors: current and future trends.

Authors:  Daniel A Orringer; Alexandra Golby; Ferenc Jolesz
Journal:  Expert Rev Med Devices       Date:  2012-09       Impact factor: 3.166

Review 7.  The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis.

Authors:  Rasheed Zakaria; Kumar Das; Maneesh Bhojak; Mark Radon; Carol Walker; Michael D Jenkinson
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

Review 8.  Current Applications of Diffusion Tensor Imaging and Tractography in Intracranial Tumor Resection.

Authors:  Jamie D Costabile; Elsa Alaswad; Shawn D'Souza; John A Thompson; D Ryan Ormond
Journal:  Front Oncol       Date:  2019-05-29       Impact factor: 6.244

9.  Selective excision of cerebral metastases from the precentral gyrus.

Authors:  Robert G Kellogg; Lorenzo F Munoz
Journal:  Surg Neurol Int       Date:  2013-05-17

10.  Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases.

Authors:  Thomas Obermueller; Michael Schaeffner; Julia Gerhardt; Bernhard Meyer; Florian Ringel; Sandro M Krieg
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.